Want to see IN:ASTERDM full AI Analyst Report?
ASTERDM Stock Chart & Stats
₹615.20
-₹6.20(-1.19%)
At close: 4:00 PM EST
₹615.20
-₹6.20(-1.19%)
Day’s Range― - ―
52-Week Range₹519.80 - ₹847.95
Previous CloseN/A
Volume549.11K
Average Volume (3M)57.99K
Market Cap
₹406.21B
Enterprise Value₹334.28K
Total Cash (Recent Filing)₹13.27B
Total Debt (Recent Filing)₹22.20B
Price to Earnings (P/E)104.9
Beta0.50
Next Earnings
Aug 06, 2026EPS Estimate
2.3Next Dividend Ex-DateN/A
Dividend Yield0.5%
Share Statistics
EPS (TTM)7.53
Shares Outstanding518,121,030
10 Day Avg. Volume86,592
30 Day Avg. Volume57,995
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)7.55
Price to Sales (P/S)7.44
P/FCF Ratio171.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)12.14
Revenue Forecast (FY)₹57.21B
Bulls Say, Bears Say
Bulls Say
Balance Sheet HealthDebt-to-equity declined to ~0.49 in FY2026 and equity strengthened versus FY2025, materially lowering financial risk. Reduced leverage increases flexibility for capex, selective expansion or debt paydown, supporting multi-quarter resilience in operations and strategic moves.
Margin StrengthFY2026 reported strong operating margins and positive revenue growth, indicating scalable hospital operations and disciplined cost structure. Durable mid-teens EBIT/near-20% EBITDA margins support reinvestment, absorb pricing pressure and provide sustained operating cash generation.
Improved Cash GenerationOperating cash flow recovered and free cash flow returned to positive (~2.0B), restoring a core funding source. Even if modest, positive FCF enhances the company's ability to fund maintenance capex, reduce leverage or finance organic growth without relying solely on external capital.
Bears Say
Earnings VolatilityReported results show uneven profitability and an atypical FY2025 net income spike, implying one-off items or timing effects. This reduces confidence in recurring earnings, complicates forecasting and weakens the predictability of returns over the next several quarters.
Cash Conversion RiskFree cash flow represented only about 30% of net income in FY2026 and cash coverage vs. net income has varied across years. Persistent working-capital or timing swings make cash generation unreliable for sustained reinvestment or steady debt reduction.
Historical Leverage & ROE VariabilityAlthough leverage improved recently, the company carried material debt in prior years and ROE has been highly variable (very high in FY2025, lower otherwise). Historical indebtedness and inconsistent returns constrain strategic optionality and increase sensitivity to demand shocks.
Aster DM Healthcare Ltd. News
ASTERDM FAQ
What was Aster DM Healthcare Ltd.’s price range in the past 12 months?
Aster DM Healthcare Ltd. lowest stock price was ₹519.80 and its highest was ₹847.95 in the past 12 months.
What is Aster DM Healthcare Ltd.’s market cap?
Aster DM Healthcare Ltd.’s market cap is ₹406.21B.
When is Aster DM Healthcare Ltd.’s upcoming earnings report date?
Aster DM Healthcare Ltd.’s upcoming earnings report date is Aug 06, 2026 which is in 8 days.
How were Aster DM Healthcare Ltd.’s earnings last quarter?
Aster DM Healthcare Ltd. released its earnings results on Apr 30, 2026. The company reported ₹2.7 earnings per share for the quarter, beating the consensus estimate of ₹1.6 by ₹1.1.
Is Aster DM Healthcare Ltd. overvalued?
According to Wall Street analysts Aster DM Healthcare Ltd.’s price is currently Overvalued.
Does Aster DM Healthcare Ltd. pay dividends?
Aster DM Healthcare Ltd. pays a Semiannually dividend of ₹3 which represents an annual dividend yield of 0.5%. See more information on Aster DM Healthcare Ltd. dividends here
What is Aster DM Healthcare Ltd.’s EPS estimate?
Aster DM Healthcare Ltd.’s EPS estimate is 2.3.
How many shares outstanding does Aster DM Healthcare Ltd. have?
Aster DM Healthcare Ltd. has 518,121,030 shares outstanding.
What happened to Aster DM Healthcare Ltd.’s price movement after its last earnings report?
Aster DM Healthcare Ltd. reported an EPS of ₹2.7 in its last earnings report, beating expectations of ₹1.6. Following the earnings report the stock price went up 0.279%.
Which hedge fund is a major shareholder of Aster DM Healthcare Ltd.?
Currently, no hedge funds are holding shares in IN:ASTERDM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd. operates as an international healthcare provider with a significant presence in India and other global regions. The company's operations are segmented across hospitals, clinics, retail pharmacies, and other diversified services. It delivers a comprehensive range of medical care, from fundamental primary care to highly specialized quaternary services, supported by a vast infrastructure. This network includes 29 hospitals, 120 clinics, 371 retail pharmacies, 114 laboratories, and numerous patient experience centers, all operating under well-known brands such as Aster, Medcare, and Access. Beyond direct patient care, the company also provides healthcare retailing, diagnostic testing, digital health solutions, and medical education. Established in 1987, Aster DM Healthcare maintains its corporate headquarters in Dubai, United Arab Emirates.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―